Preventice Technologies (now Boston Scientific Cardiac Diagnostics)

Minneapolis, Minnesota, United States (formerly Eagan, Minnesota, and Rochester, Minnesota) [1, 7, 8, 14, 15, 18]  All United States companies → — Founded 2007 [1, 6, 15]
Healthcare Conglomerate Specialty-Focused AI Wearables / RPM
Cardiology Pediatrics
Cardiology AI Wearables & Remote Monitoring (RPM)
Acquired (by Boston Scientific) [6, 7, 15, 17, 27]
Claim this company

Products

BodyGuardian Remote Monitoring System
Boston Scientific Cardiac Diagnostics
Cardiology AI
A wearable device that collects and transmits physiological data for the detection and monitoring of non-lethal cardiac arrhythmias in ambulatory patients, integrating multiple monitoring technologies and AI-powered analytics.

See all 1 product →

About Preventice Technologies (now Boston Scientific Cardiac Diagnostics)

Preventice Technologies, now operating as Boston Scientific Cardiac Diagnostics, is a healthcare AI company specializing in mobile health solutions and remote monitoring services for cardiac arrhythmias. The company’s core offering is the BodyGuardian® family of wearable cardiac monitors, which includes devices like the BodyGuardian™ MINI and MINI PLUS. These monitors are designed for both adult and pediatric patients and collect physiological data such as ECG, heart rate, respiration rate, and activity level. [1, 2, 14, 15, 19]

These wearable devices integrate with a cloud-based platform, PatientCare, which leverages artificial intelligence (AI) algorithms and human expertise from an independent diagnostic testing facility to provide near real-time analysis of ambulatory electrocardiogram data. [4, 12, 14, 15, 31] This technology aims to support physicians in timely diagnosis, treatment planning, and ongoing management of cardiac conditions like atrial fibrillation, while allowing patients to maintain their daily activities. [1, 2, 8, 12, 13, 14, 29, 30] The system offers robust data collection, a wide range of electronic medical record (EMR) integrations, and high diagnostic accuracy. [2, 29, 31] Boston Scientific’s broader cardiac diagnostics portfolio also includes implantable cardiac monitors and other electrophysiology solutions. [4, 13, 32, 34]

Focus Areas

Mobile cardiac health solutions remote patient monitoring cardiac arrhythmias ambulatory electrocardiography deep learning algorithms mHealth digital health solutions ECG interpretation

Business Intelligence

TechnologyCloud-based platform, wearable cardiac monitors (BodyGuardian® family), mobile applications, BeatLogic® deep learning algorithms (AI operating system for ECG analysis)

What Physicians Need to Know

Mobile Cardiac Health Solutions & Remote Patient Monitoring
Preventice Technologies, now Boston Scientific Cardiac Diagnostics, specializes in a comprehensive portfolio of mobile cardiac health solutions and remote patient monitoring. Their BodyGuardian® family of monitors offers various modalities including Holter, cardiac event monitoring, and mobile cardiac telemetry (MCT) through a single, waterproof, and repositionable device. This allows for continuous or intermittent heart monitoring to assess cardiac rhythm and provide reliable ECG data.
Cardiac Arrhythmias & ECG Interpretation
The company focuses on detecting and monitoring cardiac arrhythmias in ambulatory patients. Their BeatLogic™ AI algorithm is central to this, automating ECG interpretation and enabling quick delivery of accurate reports and critical notifications. BeatLogic™ was developed using over 125,000 patient records and 7.5 million ECG records, applying deep-learning models to detect and classify 34 distinct arrhythmias with high precision.
Deep Learning Algorithms & AI
A key specialization is the use of deep learning algorithms, particularly the BeatLogic™ AI algorithm, for comprehensive ECG analysis. This AI processes billions of heartbeats daily, identifying variations that could signal dangerous arrhythmias and alerting physicians to cases requiring attention. They also utilize the HeartLogic™ Heart Failure Diagnostic, an FDA-approved predictive analytic alert in implantable devices, which can predict up to 70% of worsening heart failure cases weeks in advance.
mHealth & Digital Health Solutions
Preventice Technologies offers a fully-integrated, cloud-based platform that supports their remote monitoring systems. This digital health solution, including the PatientCare Platform and BodyGuardian® wearable sensor portfolio, is designed to provide timely access to detailed and actionable data reports. They also offer BodyGuardian 360, a cloud-based platform that empowers remote patient care and simplifies workflows, with modules for Chronic Care Management (CCM) and Remote Physiologic Monitoring (RPM).
Physician Tip

For physicians, Boston Scientific Cardiac Diagnostics (formerly Preventice Technologies) offers timely and actionable insights through their remote cardiac monitoring solutions. The BodyGuardian™ monitors provide robust data collection and integrate with electronic medical records (EMR) for streamlined workflows. The BeatLogic™ AI algorithm provides highly accurate and rapid ECG interpretation, classifying 34 arrhythmias with high sensitivity, leading to faster diagnoses and informed treatment decisions. The patient-centered design of the monitors, including their waterproof nature and flexible adhesive options, aims to improve patient comfort and compliance, which in turn leads to higher quality data. Additionally, the HeartLogic™ Heart Failure Diagnostic can provide weeks of advance notice for worsening heart failure, enabling proactive intervention. The company also offers various business models and support for reimbursement, simplifying the administrative burden for practices. Physicians maintain responsibility for final ECG data interpretation and diagnosis.

Boston Scientific Cardiac Diagnostics' cardiac monitoring device portfolio integrates with Epic Aura, allowing healthcare providers to submit orders, receive results, and review reports directly within Epic. The BodyGuardian 360 platform also allows for integration of data from wearables directly into RPM and EMR dashboards. They aim for seamless integration with existing systems to reduce setup and administrative burden.

Products by Preventice Technologies (now Boston Scientific Cardiac Diagnostics)

1 product in the directory

BodyGuardian Remote Monitoring System
Boston Scientific Cardiac Diagnostics
Cardiology AI
A wearable device that collects and transmits physiological data for the detection and monitoring of non-lethal cardiac arrhythmias in ambulatory patients, integrating multiple monitoring technologies and AI-powered analytics.

What the Web Says

Preventice Technologies, now Boston Scientific Cardiac Diagnostics, offers remote cardiac monitoring solutions, primarily the BodyGuardian line of monitors. The company was acquired by Boston Scientific in 2021. Reviews indicate a mixed sentiment regarding both their products and the company as an employer. While the technology is generally seen as effective for diagnosis, there are concerns about product usability and customer support. As an employer, experiences vary, with some highlighting good work-life balance and benefits, while others point to issues with pay and management.

Overall: Mixed

Strengths

  • Timely diagnosis with fast report turnaround (24-48 hours average).
  • High diagnostic accuracy (99% final report accuracy).
  • Simplified workflow and seamless integration with existing systems like Epic Aura.
  • Patient-centered design with waterproof, comfortable, and discreet monitors.
  • Good for networking and career growth within Boston Scientific.
  • Some employees report good work-life balance and benefits.

Limitations

  • Software issues identified where ventricular tachycardia (VT) may not be identified, leading to missed critical alerts.
  • Remote monitoring availability and support can be lacking in certain regions (e.g., India).
  • Product usability issues, such as poor skin contact with patches and reliance on a separate, used phone for data transmission.
  • Difficulty finding imaging centers that work with Boston Scientific for device configuration for MRIs.
  • Some employees feel they are not paid what they are worth.
  • Reports of hectic and thankless workdays with frequent management changes.

Based on reviews from: Indeed.com, Boston Scientific Cardiac Diagnostics (Official Website), Reddit, FDA.gov, YesPress

Last updated: 2026-10-23

Videos

News, demos, and interviews about Preventice Technologies (now Boston Scientific Cardiac Diagnostics).

Loading videos...

Videos load interactively. If none appear, search YouTube for Preventice Technologies (now Boston Scientific Cardiac Diagnostics) →

View all on YouTube

Press & Coverage

The Journal of Innovations in Cardiac Rhythm Management
Preventice Solutions Presents Real-World Performance of Wearable ECG Monitoring Technology using Deep Learning Algorithms for Detecting Atrial Fibrillation
This article discusses a 2019 study validating Preventice Solutions' BodyGuardian® Remote Monitoring System with the BeatLogic™ deep learning platform for atrial fibrillation detection, leveraging AI and machine learning. The study, presented at Heart Rhythm 2019, showed high sensitivity and positive predictive value for AF detection using real-world data.
2019-05
Boston Scientific Newsroom
Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc.
Boston Scientific announced in January 2021 a definitive agreement to acquire Preventice Solutions for an upfront cash payment of $925 million, with an additional $300 million in potential commercial milestone payments. This acquisition aimed to expand Boston Scientific's rhythm management diagnostics portfolio with Preventice's mobile cardiac health solutions.
2021-01
Fierce Biotech
Boston Scientific acquires wearable cardiac sensor maker Preventice Solutions
In January 2021, Boston Scientific announced its acquisition of Preventice Solutions for $925 million, with potential additional milestone payments. Preventice, known for its BodyGuardian line of wearable cardiac sensors, recorded $158 million in net sales in 2020.
2021-01
MedTech Dive
Boston Scientific bets on cardiac wearables with $925M Preventice buy
Boston Scientific's $925 million acquisition of Preventice Solutions in January 2021 positioned the company in the rapidly growing cardiac monitoring industry. The deal, which includes potential milestone payments, adds Preventice's short-term and long-term Holter cardiac monitoring devices to Boston Scientific's offerings.
2021-01
Twin Cities Business
Boston Scientific to Buy Preventice Solutions for $925M
Boston Scientific announced in January 2021 its plan to acquire Preventice Solutions for $925 million, with potential additional payments. Preventice, founded in 2009, developed the BodyGuardian wearable medical device for remote heart monitoring.
2021-01
Medtech Insight
Boston Scientific Bets Big On Monitoring; Buys Preventice For Up To $1.25Bn
Boston Scientific's acquisition of Preventice Solutions for up to $1.25 billion in January 2021 was a significant investment in the remote diagnostics and services market. This move aimed to strengthen Boston Scientific's presence in the high-growth ambulatory electrocardiography space.
2021-01
MedCity News
Boston Scientific to acquire cardiac monitoring company Preventice for $925M
In January 2021, Boston Scientific announced its intention to acquire Preventice Solutions for $925 million in cash and up to $300 million in milestone payments. The acquisition aimed to complement Boston Scientific's existing cardiology devices with Preventice's wearable remote cardiac monitors and algorithms.
2021-01
YesPress
Preventice Solutions - Remote Cardiac Monitoring Services
Preventice Solutions, now Boston Scientific Cardiac Diagnostics, developed the BodyGuardian monitors for remote ECG data collection, combining wearable sensors with software, technicians, and reporting services. Boston Scientific acquired the business in March 2021 for an upfront payment of $925 million.
2026-10

Frequently Asked Questions

Boston Scientific Cardiac Diagnostics offers a portfolio of mobile cardiac health solutions, including the BodyGuardian family of remote patient monitoring devices. These devices are designed to detect and monitor various cardiac arrhythmias through ambulatory electrocardiography, providing physicians with actionable data for diagnosis and management. The solutions leverage mHealth and digital health technologies to facilitate continuous and convenient patient monitoring outside of traditional clinical settings.
Our deep learning algorithms are integrated into our digital health solutions to enhance ECG interpretation, aiming to improve diagnostic accuracy and efficiency. These algorithms analyze vast amounts of ECG data to identify subtle patterns and anomalies indicative of cardiac arrhythmias, which can assist physicians in making timely and informed decisions. The goal is to reduce the burden of manual ECG review and provide more precise insights into a patient's cardiac health.
Our ambulatory electrocardiography products, such as the BodyGuardian devices, are designed to provide high-quality ECG data over extended periods, addressing concerns about intermittent arrhythmias. Key features include continuous recording, patient-activated events, and automated arrhythmia detection. The systems are built to ensure data quality and provide clear, interpretable ECGs, which are then analyzed using our advanced algorithms to support accurate diagnosis.
Our mHealth and digital health solutions adhere to rigorous compliance standards and have obtained necessary regulatory approvals for cardiac monitoring. We prioritize patient safety and data security, ensuring our devices and platforms meet industry-specific regulations and guidelines. This commitment to compliance provides healthcare administrators and physicians with confidence in the reliability and trustworthiness of our cardiac diagnostic solutions.
Our pricing structure for remote patient monitoring services and devices is designed to be competitive and offers various models to suit different healthcare settings. We provide comprehensive support and training to healthcare providers, including onboarding, technical assistance, and ongoing educational resources. Our goal is to ensure seamless integration of our solutions into clinical workflows and maximize their effectiveness for patient care.
The acquisition by Boston Scientific has significantly enhanced the stability and expanded the product roadmap for Preventice Technologies' cardiac diagnostics offerings. This integration has brought greater resources for research and development, accelerating innovation in mobile cardiac health. It has also opened up new partnership opportunities, allowing us to reach a broader network of healthcare providers and patients with our advanced cardiac monitoring solutions.

Comparisons

BodyGuardian Remote Monitoring System vs Cardiomo

For a physician evaluating remote cardiac monitoring solutions, BodyGuardian Remote Monitoring System and Cardiomo both offer AI-powered wearable technology, but cater to slightly different needs. BodyGuardian, from Boston Scientific Cardiac Diagnostics, excels in comprehensive, multi-modal cardiac rhythm analysis for non-lethal arrhythmias. It integrates mobile cardiac telemetry, event monitoring, and Holter monitoring capabilities into a single […]
BodyGuardian Remote Monitoring System vs Sleepiz One+
BodyGuardian Remote Monitoring System vs PMcardio
BodyGuardian Remote Monitoring System vs EchoNext

Related Companies

TimeDoc Health
Chicago, IL

TimeDoc Health is a healthcare technology and services company that provides virtual care management solutions, primarily focusing on chronic care management (CCM), remote patient monitoring (RPM), and behavioral health integration (BHI). Their platform and services are designed to help healthcare organizations, including primary care providers, health systems, FQHCs (Federally Qualified Health Centers), and Medicare Advantage […]
Koios Care
Antwerp, Belgium

Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]
CureCompanion
Austin, Texas, USA

CureCompanion is a healthcare technology company that specializes in virtual care solutions, offering an integrated platform of hardware and software for telemedicine. Their technology goes beyond basic video conferencing, enabling healthcare providers to conduct comprehensive virtual examinations. This includes the ability to examine skin, eyes, ears, and throat using HD cameras, listen to heart and […]
Caption Health (formerly Bay Labs, now part of GE HealthCare)
San Mateo, CA, US

Caption Health, formerly known as Bay Labs and now part of GE HealthCare, is a pioneering medical artificial intelligence (AI) company dedicated to expanding access to high-quality ultrasound examinations. The company’s core offering is the Caption AI platform, which utilizes AI to guide healthcare providers, including those without extensive specialized training, in acquiring and interpreting […]
An
Anumana
Cambridge, MA, United States

Anumana is an AI-driven health technology company dedicated to transforming cardiovascular care. Co-founded by nference and Mayo Clinic, Anumana develops software-as-a-medical-device (SaMD) solutions that leverage multimodal AI to support early detection, clinical decision-making, and intraoperative guidance across the continuum of care. The company’s portfolio includes FDA-cleared ECG-based algorithms, generative imaging applications, and real-time procedural support […]
Ke
Keya Medical Technology Co.
Seattle, Washington, USA, and Beijing, China (with offices in Shanghai and Shenzhen) [1, 2, 4, 5, 6, 7, 8, 16]

Keya Medical Technology Co. is an international medical technology company specializing in deep learning-based AI solutions for non-invasive disease diagnosis and treatment. The company, founded in 2016, develops AI-enabled diagnostic devices that aim to enhance efficiency, accuracy, and precision in healthcare across various specialties, including cardiology, neurology, pulmonology, pathology, and surgery. [2, 4, 8, 14] […]
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.